drugset / Trial / NCT01519128
A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to investigate the effect of steady-state (constant concentration of medication in the blood) TMC278 on the single dose pharmacokinetics (what the body does to the medication) of digoxin.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Digoxin | Other / unclassified | 0.5 mg | Oral |
| Subject | Rilpivirine | Small molecule | 25 mg | Oral |
Indications
No indication recorded.